Expert panel says new $56K Alzheimers drug is unproven—and worth $8400 max – Ars Technica

Enlarge/ The exterior of the headquarters of biotechnology company Biogen in Cambridge, Massachusetts.
47 with 37 posters participating
Biogen’s new Alzheimer’s drug Aduhelm continues to face oppo… [+3272 chars]